Drug Trial Radar · NCT05977140
CDI-988 Safety Study in Healthy Participants
Last checked: Nov 19, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
94
Actual
Start
Sep 27, 2023
Primary completion
May 23, 2025
Study completion Jul 23, 2025
Sponsor
- Lead sponsor
- Cocrystal Pharma, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Cocrystal Pharma Australia Pty Ltd.; Beyond Drug Development Pty Ltd.; Resolutum Global Pty Ltd.; Scientia Clinical Research Pty Ltd
- First posted
- Aug 4, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn about the safety and pharmacokinetics (PK, the amount of drug in the blood) of a new drug called CDI-988 in healthy volunteers. The main questions it aims to answer are: * Are there any side effects of the drug? * What is the amount of drug that reaches the bloodstream? Participants will be assigned by chance to take either CDI-988 or placebo by mouth and have physical exams, electrocardiograms (ECGs), vital signs, and blood tests to look for any side effects.
Conditions
- Healthy Volunteers
Interventions
CDI-988Drug
SARS-CoV-2 3CL protease inhibitor
PlaceboDrug
matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventsTime frame: Up to 17 days
- Laboratory AbnormalitiesTime frame: Up to 17 days
- Vital SignsTime frame: Day 1 to 7 days after last dose
- ECGsTime frame: Day 1 to 7 days after last dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Scientia Clinical Research Pty Ltd
Randwick, New South Wales, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.